Clinical trial
Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute…
NCT00403234 · Purdue Pharma LP, Industry · Terminated
Key facts
| NCT number | NCT00403234 |
|---|---|
| Title | Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement |
| Official title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study to Evaluate the Analgesic Efficacy of BTDS on Postoperative Pain During Rehabilitation Following Total Knee Arthroplasty |
| Lead sponsor | Purdue Pharma LP, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Postoperative Pain |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal patch, Placebo BTDS |
| Enrollment | 10 |
| Start date | Nov 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Nov 23, 2006 |
| Last update posted | Sep 3, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: